‘There Is Definitely No One Way To Treat Myeloma’ Dr. James Berenson (IMBCR)...
Dr. James Berenson’s interview with Patient Power sums up everything that was exciting and happening in the myeloma research world in the last ten years. The myeloma drugs that are being studied and...
View ArticleDr. Shaji K. Kumar Compares Millennium’s MLN9708 And Bortezomib/Velcade (Video)
Dr. Shaji K. Kumar MD, from Hematology Division at Mayo Clinic, Rochester, Minnesota, presented the clinical trial results with MLN9708 at the ASH 2012. MLN9708 is the first oral proteasome...
View ArticleCure Talk Interviews Dan Zenka, VP, Communications, Prostate Cancer...
Dan Zenka, senior vice president of the Prostate Cancer Foundation was diagnosed with prostate cancer in April 2012 at the age of 51. He blogs to share information and patient perspectives and most...
View ArticleJoin Us on Myeloma Cure Panel Talk Show with Dr. Shaji Kumar and Dr. Edward...
If you have not registered for the myeloma panel, mail Priya@trialx.com for dial-in information and you might just be able to reserve your slot. Dr. Kumar and Dr. Faber will be talking on the topic:...
View ArticleLive Blogging the Myeloma Cure Panel with Dr. Shaji Kumar and Dr. Faber :...
Listen to internet radio with The Cure Panel Talk Show on Blog Talk Radio 7:05 – We come to an end – we had more than 25 listeners on the call and so much information that we could not keep up. We will...
View ArticleStanford University Scientist, Dr. Bikul Das and Team Reveal TB Hideout And...
In a latest study by Dr. Bikul Das, (he discovered altruism in embryonic stem cells and their link to cancer) and team, the tuberculosis bacteria, Mycobacterium tuberculosis, have been found to...
View Article‘Myeloma Patients Living Longer’ – The Cure Panel Talk Show with Dr. Shaji K....
We had a very informative and comprehensive panel with Dr. Kumar and Dr. Faber shooting out results of drugs used in combination as well as new drugs on the myeloma block. Barring a few technical...
View ArticleStanford Scientist, Dr. Bikul Das In Conversation With CureTalk on His TB...
CureTalk reached out to Dr. Bikul Das regarding his latest study on TB bacteria found in mesenchymal stem cells opening up new avenues to target latent TB. Dr. Bikul Das is postdoctoral research fellow...
View ArticleThere is a NEW FUTURE in Multiple Myeloma Treatments – Survival Rates and...
Gary Petersen, editor myelomasurvival.com and co-host of Cure Panel Talk Show has written a brilliant blog on the recently held January Cure Panel Talk Show on multiple myeloma. Gary has been...
View ArticleThe Cure Talk Round-Up: Dan Zenka, Dr. Bikul Das, Dr.Nilanjan Chatterjee,...
We are into February, the month for Cancer Prevention and Valentine’s Day. February would see us follow prostate cancer, schizophrenia, and heart health in addition to latest in multiple myeloma, and...
View ArticleCureTalk Interviews Dan Hennessey, Prostate Cancer Survivor, Advocate, And...
Dan Hennessey was diagnosed with prostate cancer 6 years ago and in his own words, ‘has seen life go from ordinary to extraordinary’. During his battle and victory against prostate cancer, Dan has...
View ArticleCureTalk Interviews Dan Hennessey – Part 2 – Views On PSA Test, Treatment...
Continued from Part 1… Me: Routine PSA test for prostate cancer screening is not encouraged by the USPTF. What is your opinion on this? Dan: I know there are lots of issues around the validity of PSA...
View ArticleWhy Is Celgene’s POMALYST (Pomalidomide) FDA Approval For Advanced Myeloma...
The internet is rife with articles on the new drug, POMALYST’s FDA approval for advanced multiple myeloma. The US Food and Drug Administration approved pomalidomide to treat patients with multiple...
View ArticleWould New Depression Therapy tDCS (Transcranial Direct Current Stimulation)...
An experimental therapy in which a mild current is used for stimulation of brain has been found to be very effective in relieving depression, reports NYTimes. The therapy known as transcranial direct...
View ArticleProstate Cancer Hormone Therapy Duration Halved With Same Effects
Seems like shorter treatments for prostate cancer are as effective as longer duration treatments if the results of a new study on prostate cancer are anything to go by, reports NYTimes. This may well...
View ArticleDr. Parameswaran Hari On FDA’s POMALYST Approval
POMALYST (pomalidomide) has been approved for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease...
View ArticleA Valentine’s Day Message From CureTalk
Dear Readers, As we celebrate the day of LOVE, let us pause and give a thought to the lives that were lost or snatched away in the last year due to the lack of this very feeling – LOVE. The world...
View ArticleFebruary Myeloma Cure Panel Co-hosted By Pat Killingsworth Devoted to...
The Cure Panel Talk Show for February has been scheduled for Thursday, 28 February @ 6pm EST. This is the sixth episode of Cure Panel Talk Show on Multiple Myeloma and we thank everyone who has...
View ArticleFDA Approves First US Artificial Retina, Argus II, Providing Limited Vision...
Marking a milestone in the research of retinal diseases, the FDA approved the first ‘artificial retina’ for people rendered blind by genetic disorder, retinitis pigmentosa, presented as slow...
View ArticleCure Talk Interviews Cameron Von St. James Caregiver, Blogger, and Champion...
Cameron is husband to Heather Von St. James, survivor advocate for Mesothelioma Cancer Alliance, and father to Lily Rose. When Lily Rose was just 3 ½ months old, Heather was diagnosed with...
View Article
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/17/balaghat-4-2026-09-17-19-01-31.png)
